180 related articles for article (PubMed ID: 3228083)
1. The Prescription Drug Marketing Act of 1987.
Greenberg RB
Am J Hosp Pharm; 1988 Oct; 45(10):2118-26. PubMed ID: 3228083
[TBL] [Abstract][Full Text] [Related]
2. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures. Food and Drug Administration, HHS. Final rule.
Fed Regist; 1999 Dec; 64(232):67720-63. PubMed ID: 11010665
[TBL] [Abstract][Full Text] [Related]
3. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record.
Fed Regist; 2000 May; 65(86):25639-41. PubMed ID: 11010689
[TBL] [Abstract][Full Text] [Related]
4. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
5. The prescription drug marketing act: a solution in search of a problem?
Angarola RT; Beach JE
Food Drug Law J; 1996; 51(1):21-55. PubMed ID: 11794352
[No Abstract] [Full Text] [Related]
6. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date. Final rule; delay of effective date.
Food and Drug Administration, HHS
Fed Regist; 2004 Feb; 69(35):8105-7. PubMed ID: 14997866
[TBL] [Abstract][Full Text] [Related]
7. Legal implications of hospital resales of pharmaceuticals. American Hospital Association Office of General Counsel.
Am J Hosp Pharm; 1986 Aug; 43(8):1951-7. PubMed ID: 3752135
[TBL] [Abstract][Full Text] [Related]
8. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
Alder HC
Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
[TBL] [Abstract][Full Text] [Related]
9. Distribution of blood derivatives by registered blood establishments that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; delay of applicability date. Final rule; delay of applicability date.
Food and Drug Administration, HHS
Fed Regist; 2006 Nov; 71(218):66108-9. PubMed ID: 17099971
[TBL] [Abstract][Full Text] [Related]
10. Distribution of certain drug products by registered blood establishments and comprehensive hemophilia diagnostic treatment centers that qualify as health care entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements and administrative procedures. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Oct; 73(197):59496-501. PubMed ID: 18985968
[TBL] [Abstract][Full Text] [Related]
11. Final notice regarding section 602 of the Veterans Health Care Act of 1992 entity guidelines--PHS. Final notice.
Fed Regist; 1994 May; 59(92):25110-4. PubMed ID: 10134125
[TBL] [Abstract][Full Text] [Related]
12. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
[TBL] [Abstract][Full Text] [Related]
13. The history and contemporary challenges of the US Food and Drug Administration.
Borchers AT; Hagie F; Keen CL; Gershwin ME
Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical marketing practices: balancing public health and law enforcement interests; moving beyond regulation-through-litigation.
Zalesky CD
J Health Law; 2006; 39(2):235-64. PubMed ID: 17002233
[TBL] [Abstract][Full Text] [Related]
15. Prescription Drug Marketing Act Pedigree Requirements; effective date and compliance policy guide; request for comment. Final rule; announcement of effective date; notice of availability; request for comment.
Food and Drug Administration, HHS
Fed Regist; 2006 Jun; 71(114):34249-51. PubMed ID: 16795943
[TBL] [Abstract][Full Text] [Related]
16. Summary of 1990 Medicaid drug rebate legislation. ASHP Government Affairs Division.
Am J Hosp Pharm; 1991 Jan; 48(1):114-7. PubMed ID: 2000867
[TBL] [Abstract][Full Text] [Related]
17. An overview of the FDA publication Approved Drug Products with Therapeutic Equivalence Evaluations.
Knoben JE; Scott GR; Tonelli RJ
Am J Hosp Pharm; 1990 Dec; 47(12):2696-700. PubMed ID: 2278285
[TBL] [Abstract][Full Text] [Related]
18. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
[TBL] [Abstract][Full Text] [Related]
19. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
[TBL] [Abstract][Full Text] [Related]
20. Content and format for labeling for human prescription drugs; amendment of effective date for certain biological products--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(15 pt 1):7271-3. PubMed ID: 10249526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
